Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stott

Showing results (331-340 of 423) with videos related to

Pageof 43
Sort By:
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.
Plos One|June 6, 2012
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapyDov Shiffman, Stella Trompet, Judy Z Louie, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
BMC Geriatrics|September 19, 2018
Diagnostic test accuracy of a novel smartphone application for the assessment of attention deficits in delirium in older hospitalised patients: a prospective cohort study protocolLisa-Marie Rutter, Eva Nouzova, David J Stott, et al.
Frontiers in Endocrinology|June 7, 2021
Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled TrialsLaurien E Zijlstra, J Wouter Jukema, Rudi G J Westendorp, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at RiskP J Houx, J Shepherd, G-J Blauw, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2022
No Effect of Levothyroxine on Hemoglobin in Older Adults With Subclinical Hypothyroidism: Pooled Results From 2 Randomized Controlled TrialsRobert S Du Puy, Rosalinde K E Poortvliet, Simon P Mooijaart, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Plos One|January 25, 2020
A smartphone-based test for the assessment of attention deficits in delirium: A case-control diagnostic test accuracy study in older hospitalised patientsZoë Tieges, David J Stott, Robert Shaw, et al.
Pageof 43

Showing results (331-340 of 423) with videos related to

Sort By:
Pageof 43
The American Journal of Cardiology|November 24, 1999
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at RiskJ Shepherd, G J Blauw, M B Murphy, et al.
Plos One|June 6, 2012
Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapyDov Shiffman, Stella Trompet, Judy Z Louie, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
BMC Geriatrics|September 19, 2018
Diagnostic test accuracy of a novel smartphone application for the assessment of attention deficits in delirium in older hospitalised patients: a prospective cohort study protocolLisa-Marie Rutter, Eva Nouzova, David J Stott, et al.
Frontiers in Endocrinology|June 7, 2021
Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled TrialsLaurien E Zijlstra, J Wouter Jukema, Rudi G J Westendorp, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at RiskP J Houx, J Shepherd, G-J Blauw, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2022
No Effect of Levothyroxine on Hemoglobin in Older Adults With Subclinical Hypothyroidism: Pooled Results From 2 Randomized Controlled TrialsRobert S Du Puy, Rosalinde K E Poortvliet, Simon P Mooijaart, et al.
Circulation|February 7, 2007
C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Naveed Sattar, Heather M Murray, Alex McConnachie, et al.
Plos One|January 25, 2020
A smartphone-based test for the assessment of attention deficits in delirium: A case-control diagnostic test accuracy study in older hospitalised patientsZoë Tieges, David J Stott, Robert Shaw, et al.
Pageof 43